Development and validation of a Behçet's Disease Damage Index for adults with BD: An Explicit, Composite and Rated (ECR) tool.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gheita Tamer A, Hammam Nevin, Fawzy Samar M, Abd El-Latif Eiman, El-Gazzar Iman I, Samy Nermeen, El-Hammady Dina H, Abdel Noor Rasha, El-Shebini Emad, El-Najjar Amany R, Eesa Nahla N, Salem Mohamed N, Ibrahim Soha E, El-Essawi Dina F, Elsaman Ahmed M, Senara Soha, Fathi Hanan M, Sallam Rehab A, El Shereef Rawhya R, Abd Elazeem Mervat I, Fawzy Rasha M, Khalil Noha M, Shahin Dina, El-Saadany Hanan M, ElKhalifa Marwa, Nasef Samah I, Abdalla Ahmed M, Noshy Nermeen, Said Emtethal A, Saad Ehab, Moshrif Abdel Hafeez, El-Shanawany Amira T, Abdel-Fattah Yousra H, Raafat Hala A, Khalil Hossam M, Egyptian College of Rheumatology-Behçet's Disease Study Group (ECR-BDSG)
Аннотация
OBJECTIVES: This aim was to develop and validate a simple BD Damage Index (BDI).
METHODS: This was a nationwide study including 1252 BD patients. The work consisted of 3 stages. Stage 1: items generation for score content. Stage 2: items selection for the draft score was performed by an expert rheumatologist. Stage 3: the content validity of the draft score was assessed and BDI, Vasculitis Damage Index (VDI), Antineutrophil cytoplasmic antibody-associated Vasculitis Index of Damage (AVID) and Combined Damage Assessment Index (CDAI) were calculated and compared.
RESULTS: The mean age of the BD patients was 36.1 ± 9.9 years. Stages 1 and 2 resulted in a BDI instrument containing 73 items with a maximum score of 100. Stage 3, the VDI, CDAI, AVID, and BDI were 2.9 ± 2.2, 3.1 ± 2.3, 3.1 ± 2.3 and 5.1 ± 2.9, respectively. High correlations (r = .9) between comparable damage scores assured acceptable concurrent validity.
CONCLUSION: The proposed BDI represents a new robust and potentially useful tool when dealing with BD chronic status.